A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies
Effect of prior chemotherapy on hematopoietic stem cell mobilization
Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma
Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation
High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation
Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning
Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation
Escherichia coli-nitroreductase suicide gene control of human telomerase reverse transcriptase-transduced minor histocompatibility antigen-specific cytotoxic T cells
Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia
Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients
Reply from Jose A Pérez Simón on behalf of the authors